Food and Drug
Administration
Vaccines and Related Biological Products Advisory Committee
November 20, 2008
SLIDES
Overview of Research/Office Site Review Process, Center for Biologics Evaluation and Research (CBER), Carolyn Wilson, Ph.D., FDA (htm)
Overview Office of Vaccines Research and Review (OVRR), CBER, Konstantin Chumakov, Ph.D., FDA (htm)
Overview Division of Viral Products (DVP), OVRR, Jerry Weir, Ph.D., FDA (htm)
Overview Laboratory of DNA Viruses, DVP, Philip Krause, Ph.D., FDA (htm)
Up
| AC Home Page